Source: BIOSPACE

NextSource Biotechnology: <b>NextSource Biotechnology</b> Gains FDA Approval For Use Of Tradename Gleostine??? (Lomustine), An Anti-Cancer Chemotherapy Agent

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Robert Dicrisci's photo - Chairman & CEO of NextSource Biotechnology

Chairman & CEO

Robert Dicrisci

CEO Approval Rating

- -/100

Read more